WallStreetZenWallStreetZen

NASDAQ: RNAZ
Transcode Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Transcode Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RNAZ annual revenue was $0.0, with N/A growth year-over-year.

RNAZ revenue history

Current Revenue
$0.0
Current Earnings
-$16.8M
Current Profit Margin
0%

Be the first to know when RNAZ announces revenue.

RNAZ Revenue History By Year

RNAZ Yearly RevenueRNAZ RevenueRNAZ ChangeRNAZ Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A

1 of 1

Transcode Therapeutics Revenue FAQ

What was RNAZ's revenue last quarter?

Transcode Therapeutics (NASDAQ: RNAZ) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Transcode Therapeutics's revenue was $0.00.

What was Transcode Therapeutics's revenue in 2024?

Transcode Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Transcode Therapeutics make in a day?

Based on Transcode Therapeutics annual revenue for the past five years, RNAZ makes an average of $0.00 per day.

What was Transcode Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Transcode Therapeutics's revenue has grown null year over year. Transcode Therapeutics's revenue in the past year totaled $0.00.

How much does Transcode Therapeutics make in a year?

Transcode Therapeutics's revenue by year for the past five years is:
  • Transcode Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Transcode Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Transcode Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Transcode Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Transcode Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.